Fig. 3From: Augmentation of histone deacetylase 3 (HDAC3) epigenetic signature at the interface of proinflammation and insulin resistance in patients with type 2 diabetesHDAC3 activity in PBMCs from control (NGT) subjects and type 2 diabetes mellitus (T2DM) patients—combined gender (a), males (b), and females (c). HDAC3 activity expressed in pmol/min/mL. Bars represent the mean ± SEM, *p < 0.001 compared to control subjectsBack to article page